title: [Mistletoe extract for treatment of urological tumors].
abstract: In Germany misteltoe extract is one of the most commonly used complementary therapeutic strategies in oncology. There are anthroposophical as well as phytotherapeutic concepts to explain the potential mechanism of action; however, the oncological and uro-oncological literature lacks definitive proof to support recommendations on which is the most effective drug, the optimal dose, a clear indication or its efficacy. Weighting the current data, potential side effects and contraindications, the application of mistletoe extract in daily uro-oncological practice requires careful consideration of the indications in the context of a detailed patient informed consent and request for this unique therapeutic modality.
authors.affiliation: Urologikum Hamburg, Hamburg, Deutschland.
authors.forename: H
authors.initials: H
authors.lastname: Suttmann
authors.forename: M
authors.initials: M
authors.lastname: Saar
authors.forename: C H
authors.initials: CH
authors.lastname: Ohlmann
authors.forename: M
authors.initials: M
authors.lastname: Stöckle
authors.forename: J
authors.initials: J
authors.lastname: Kamradt
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D014784:Mistletoe / Q000737:chemistry*; D008517:Phytotherapy / Q000639:trends*; D010936:Plant Extracts / Q000627:therapeutic use*; D016896:Treatment Outcome; D014571:Urologic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D010936:Plant Extracts